P. Piboonsiri

发表

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

S. Iamsirithaworn, A. Wanitchang, K. Srisutthisamphan, 2022, Vaccines.

Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine

P. Thawong, A. Wanitchang, K. Srisutthisamphan, 2021, medRxiv.

Risk for Prison-to-Community Tuberculosis Transmission, Thailand, 2017–2020

M. Murray, H. Yanai, S. Nedsuwan, 2023, Emerging infectious diseases.

Molecular Epidemiological Information System to Support Management of Multidrug-Resistant Tuberculosis in Thailand: Abstract.

Areeya Disratthakit, Penpitcha Thawong, Pundharika Piboonsiri, 2020, Online journal of public health informatics.